S. 465 · 108th Congress
Access to Innovation for Medicare Patients Act of 2003
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MurraySponsor15 cosponsors · 10 D, 4 R, 1 I
D
Cantwell
SC
R
Collins
ML
D
Landrieu
BM
D
Mikulski
JR
D
Reed
GS
R
Smith
PS
D
Sarbanes
OS
R
Snowe
BL
D
Lincoln
JJ
I
Jeffords
JB
D
Bingaman
HC
D
Clinton
TD
D
Daschle
TJ
D
Johnson
LC
R
Chafee6 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Access to Innovation for Medicare Patients Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or a biological that otherwise cannot be self-administered.
What it does: CRS summary · Introduced in Senate · Feb 27, 2003
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Access to Innovation for Medicare Patients Act of 2003
Latest action (Feb 27, 2003): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Feb 27, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.